Loading…
XOMA Royalty Corporation is projected to rise to $68.53 by 2027, a +55% move from its current price of $44.22. XOMA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $43.73 | $44.28 | $44.83 | +0.13% |
| Jul 14 | $43.57 | $44.34 | $45.13 | +0.27% |
| Jul 15 | $43.45 | $44.40 | $45.37 | +0.41% |
| Jul 16 | $43.37 | $44.46 | $45.58 | +0.54% |
| Jul 17 | $43.30 | $44.52 | $45.77 | +0.68% |
| Jul 18 | $43.24 | $44.58 | $45.96 | +0.81% |
| Jul 19 | $43.19 | $44.64 | $46.13 | +0.95% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $43.19 | $44.64 | $46.13 | +0.95% |
| Week 2 | $43.01 | $45.06 | $47.21 | +1.90% |
| Week 3 | $42.97 | $45.49 | $48.16 | +2.87% |
| Week 4 | $43.00 | $45.92 | $49.04 | +3.84% |
| Week 5 | $43.07 | $46.36 | $49.89 | +4.83% |
| Week 6 | $43.17 | $46.79 | $50.72 | +5.82% |
| Week 7 | $43.30 | $47.24 | $51.53 | +6.83% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets.
It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
XOMA Royalty Corporation (XOMA) is a healthcare equity traded under the symbol XOMA. It is currently priced at $45.00 and has a market capitalization of $795.54M, ranking at 2715. These figures place it within the broader biotech royalty space as a defined asset with a portfolio of milestone and royalty revenue interests.
The near-term outlook is underscored by a bullish technical posture and a price setup that aligns with notable upside in the multi-year forecast.
A major floor 42.2% below — a decisive break under it would weaken the trend.
The nearest floor, 5.7% below — buyers have tended to step in here.
Price is pressing into resistance (1.8% away) — a breakout level to watch.
A major ceiling 6.2% above — clearing it would confirm fresh momentum.
Key XOMA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of XOMA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $44.35 | Sell | $44.19 | Buy |
| MA 10 | $43.42 | Buy | $43.65 | Buy |
| MA 20 | $42.67 | Buy | $43.00 | Buy |
| MA 50 | $42.07 | Buy | $41.23 | Buy |
| MA 100 | $36.67 | Buy | $38.22 | Buy |
| MA 200 | $33.69 | Buy | $34.83 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 70.48 | Sell |
| Stoch RSI (14) | 40.32 | Neutral |
| CCI (20) | 118.23 | Buy |
| Williams %R (14) | -25.57 | Info |
| MACD (12,26,9) | 0.20 | Buy |
| ROC (12) | 5.41 | Buy |
| Bollinger %B (20,2) | 0.87 | Neutral |
| Stochastic %K (14) | 74.43 | Neutral |
| TRIX (15) | 0.18 | Buy |
| Awesome (5,34) | 2.03 | Buy |
| Ultimate (7,14,28) | 76.05 | Sell |
| Momentum (10) | 2.02 | Buy |
| Aroon Osc (25) | 92.00 | Buy |
| Hull MA (9) | 45.11 | Sell |
| ADX (14) | 38.35 | Buy |
| ATR (14) | 0.30 | Info |
The 14-day RSI is 90, indicating overbought conditions despite a bullish stance. The 50-day simple moving average is $41.95, above the 200-day simple moving average of $33.61, signaling positive momentum.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $22.89 | $44.22 | $68.26 | 0% | Neutral | |
| $56.13 | $68.53 | $87.48 | +55% | Bullish | |
| $70.64 | $87.87 | $115.20 | +99% | Bullish | |
| $83.86 | $105.93 | $141.83 | +140% | Bullish | |
| $90.50 | $115.86 | $157.92 | +162% | Bullish | |
| $105.98 | $137.34 | $190.16 | +211% | Bullish | |
| $121.22 | $158.85 | $223.09 | +259% | Bullish | |
| $148.51 | $196.66 | $279.76 | +345% | Bullish | |
| $184.64 | $246.95 | $355.49 | +458% | Bullish | |
| $198.16 | $267.54 | $389.42 | +505% | Bullish | |
| $322.83 | $454.59 | $693.41 | +928% | Bullish | |
| $726.43 | $1,097.08 | $1,793.80 | +23.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $22.89 | $44.22 | $54.13 | +0.00% |
| August 2026 | $41.60 | $48.70 | $58.23 | +10.13% |
| September 2026 | $42.51 | $50.00 | $60.26 | +2.68% |
| October 2026 | $43.41 | $51.26 | $62.19 | +2.52% |
| November 2026 | $45.49 | $53.91 | $65.76 | +5.17% |
| December 2026 | $46.83 | $55.68 | $68.26 | +3.28% |
Click any year to see its month-by-month XOMA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
XOMA Royalty Corporation's 2026 outlook centres on $44.22, within a $22.89 to $68.26 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, XOMA could reach as high as $87.48, with a base case around $68.53 and support toward $56.13 — roughly +55% from $44.22. Buyers look set to stay in control over this stretch.
Expect XOMA to range from $70.64 to $115.20 through 2028. The $87.87 average target implies a +99% move from current prices. That is up +28% on the projected 2027 average. Momentum favours further upside here.
The XOMA price prediction for 2029 points to an average of $105.93 (low $83.86, high $141.83) — a potential gain of +140% on today's $44.22. Buyers look set to stay in control over this stretch.
In 2030, XOMA is projected to trade between $90.50 and $157.92, averaging $115.86 — a potential gain of +162% from today's $44.22. That is up +9% on the projected 2029 average. Momentum favours further upside here.
XOMA Royalty Corporation's 2031 outlook centres on $137.34, within a $105.98 to $190.16 range. That is up +19% on the projected 2030 average. That marks a +211% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, XOMA could reach as high as $223.09, with a base case around $158.85 and support toward $121.22 — roughly +259% from $44.22. Momentum favours further upside here.
Expect XOMA to range from $148.51 to $279.76 through 2033. The $196.66 average target implies a +345% move from current prices. That is up +24% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The XOMA price prediction for 2034 points to an average of $246.95 (low $184.64, high $355.49) — a potential gain of +458% on today's $44.22. Momentum favours further upside here.
In 2035, XOMA is projected to trade between $198.16 and $389.42, averaging $267.54 — a potential gain of +505% from today's $44.22. That is up +8% on the projected 2034 average. Buyers look set to stay in control over this stretch.
XOMA Royalty Corporation's 2040 outlook centres on $454.59, within a $322.83 to $693.41 range. That is up +70% on the projected 2035 average. That marks a +928% change versus current levels. Momentum favours further upside here.
By 2050, XOMA could reach as high as $1,793.80, with a base case around $1,097.08 and support toward $726.43 — roughly +23.8x from $44.22. Buyers look set to stay in control over this stretch.
Investing $1,000 in XOMA today (≈ 22.614202 XOMA) could be worth
$24,809.48
+$23,809.48 (+2381%) by 2050 · US Dollar
Based on the average projected XOMA price of $1,097.08 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in XOMAwould be worth at today's price.
$1,000 invested in XOMA on Jul 10, 2025 (≈ 35.842294 XOMA) would be worth
$1,584.95
+$584.95 (+58.5%) today · 1.58× · US Dollar
Based on a XOMA entry price of $27.9 vs. today's $44.22.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $43 | $1,028.37 | +2.8% |
| 1 month ago | $41.76 | $1,058.91 | +5.9% |
| 3 months ago | $36.74 | $1,203.59 | +20.4% |
| 6 months ago | $26.79 | $1,650.62 | +65.1% |
| 1 year ago | $27.9 | $1,584.95 | +58.5% |
| All time (5.0y) ago | $32.84 | $1,346.53 | +34.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our XOMA forecast.
Our base-case forecast reaches $88.00 around 2029.
Implied market cap at $88.00: $1.56B
Forecasts show a bullish trajectory across the next decades, with the average price rising from $45.00 in 2026 to $117.31 in 2030 and continuing higher thereafter. By 2030 the avg is $117.31 with a max of $159.93 and an ROI of 160.7%. The long-range view extends to 2040 with an avg of $459.80 and an ROI of 921.8%, and to 2050 with an avg of $1,100.35 and a max of $1,799.25, yielding an ROI of 2345.2%.
These figures reflect optimistic sentiment for the asset, though they are estimates and not guarantees. The forecasts span 2026 through 2050, showing consistent upside alongside bullish sentiment.
Tap a question to reveal the answer.
2030 has an avg forecast of $117.31, a min of $91.63, and a max of $159.93 with a ROI of 160.7% and bullish sentiment.
Forecasts show bullish sentiment for years after 2026, with increasing average prices (e.g., $45.00 in 2026 to $117.31 in 2030) and positive ROIs, but these are estimates and not guarantees.
yes—the 2050 forecast lists an avg of $1,100.35 and a max of $1,799.25, with an ROI of 2345.2%.
The current price is $45.00 and the market cap is $795.54M.
RSI(14) is 90, indicating overbought conditions with bullish momentum. The 50-day SMA is $41.95 and the 200-day SMA is $33.61. Support is at $41.69 and resistance at $45.00; the 30-day range is $41.45 to $48.85.
XOMA Royalty Corporation Community Discussion
0Share your XOMA Royalty Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.